| Brett P Siemon, | |
|
2900 W Oklahoma Ave, Milwaukee, WI 53215-4330 | |
| (414) 649-6000 | |
| Not Available |
| Full Name | Brett P Siemon |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology Assistant |
| Experience | 4 Years |
| Location | 2900 W Oklahoma Ave, Milwaukee, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073132437 | NPI | - | NPPES |
| 100102500 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | (* (Not Available)) | Secondary |
| 367H00000X | Anesthesiologist Assistant | 164 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mount Carmel New Albany Surgical Hospital | New albany, OH | Hospital |
| Mount Carmel St Ann's | Westerville, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Consultant Anesthesiologists Inc. | 3577467109 | 62 |
| Osu Observation Medicine, Llc | 3375692270 | 370 |
News Archive
BioTime, Inc., an Alameda-based company engaged in research and development of innovative new products in the field of regenerative medicine utilizing stem cells and related technology, announced today that it has formed a new wholly owned subsidiary, BioTime Acquisition Corporation, to pursue opportunities and acquire assets and businesses in the fields of stem cells and regenerative medicine.
University of Kentucky Markey Cancer Center Researcher Jessica Blackburn has earned a prestigious National Institutes of Health's New Innovator Award, a grant totaling $1.5 million over five years to fund pediatric cancer research.
A unique compound originally isolated from sharks could prove to be a promising treatment for hepatitis B and C and other viral diseases, researchers say. Known as squalamine, the drug has not yet been tested as an antiviral agent in humans, but it has been given to hundreds of people enrolled in clinical trials designed to test its usefulness for other conditions. Researchers say they hope to begin human trials to test the compound's antiviral activity within the next year.
Dotmatics, a leading provider of scientific informatics solutions and services, announced MorphoSys will implement Vortex to analyse and visualise their screening data enabling rapid, informed decision making. MorphoSys choose Vortex because of the intuitive nature of the product and its extensive drug discovery capabilities.
With summer coming to a close, the American Society for Therapeutic Radiology and Oncology has published a new brochure to help the public understand the signs and symptoms of skin cancer as well as learn the treatment options for the disease.
› Verified 8 days ago
| Entity Name | Consultant Anesthesiologists Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457420580 PECOS PAC ID: 3577467109 Enrollment ID: O20031125000053 |
News Archive
BioTime, Inc., an Alameda-based company engaged in research and development of innovative new products in the field of regenerative medicine utilizing stem cells and related technology, announced today that it has formed a new wholly owned subsidiary, BioTime Acquisition Corporation, to pursue opportunities and acquire assets and businesses in the fields of stem cells and regenerative medicine.
University of Kentucky Markey Cancer Center Researcher Jessica Blackburn has earned a prestigious National Institutes of Health's New Innovator Award, a grant totaling $1.5 million over five years to fund pediatric cancer research.
A unique compound originally isolated from sharks could prove to be a promising treatment for hepatitis B and C and other viral diseases, researchers say. Known as squalamine, the drug has not yet been tested as an antiviral agent in humans, but it has been given to hundreds of people enrolled in clinical trials designed to test its usefulness for other conditions. Researchers say they hope to begin human trials to test the compound's antiviral activity within the next year.
Dotmatics, a leading provider of scientific informatics solutions and services, announced MorphoSys will implement Vortex to analyse and visualise their screening data enabling rapid, informed decision making. MorphoSys choose Vortex because of the intuitive nature of the product and its extensive drug discovery capabilities.
With summer coming to a close, the American Society for Therapeutic Radiology and Oncology has published a new brochure to help the public understand the signs and symptoms of skin cancer as well as learn the treatment options for the disease.
› Verified 8 days ago
| Entity Name | Osu Observation Medicine, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407095052 PECOS PAC ID: 3375692270 Enrollment ID: O20090526000354 |
News Archive
BioTime, Inc., an Alameda-based company engaged in research and development of innovative new products in the field of regenerative medicine utilizing stem cells and related technology, announced today that it has formed a new wholly owned subsidiary, BioTime Acquisition Corporation, to pursue opportunities and acquire assets and businesses in the fields of stem cells and regenerative medicine.
University of Kentucky Markey Cancer Center Researcher Jessica Blackburn has earned a prestigious National Institutes of Health's New Innovator Award, a grant totaling $1.5 million over five years to fund pediatric cancer research.
A unique compound originally isolated from sharks could prove to be a promising treatment for hepatitis B and C and other viral diseases, researchers say. Known as squalamine, the drug has not yet been tested as an antiviral agent in humans, but it has been given to hundreds of people enrolled in clinical trials designed to test its usefulness for other conditions. Researchers say they hope to begin human trials to test the compound's antiviral activity within the next year.
Dotmatics, a leading provider of scientific informatics solutions and services, announced MorphoSys will implement Vortex to analyse and visualise their screening data enabling rapid, informed decision making. MorphoSys choose Vortex because of the intuitive nature of the product and its extensive drug discovery capabilities.
With summer coming to a close, the American Society for Therapeutic Radiology and Oncology has published a new brochure to help the public understand the signs and symptoms of skin cancer as well as learn the treatment options for the disease.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brett P Siemon, 3301 W Forest Home Ave, Milwaukee, WI 53215-2843 Ph: (414) 649-6000 | Brett P Siemon, 2900 W Oklahoma Ave, Milwaukee, WI 53215-4330 Ph: (414) 649-6000 |
News Archive
BioTime, Inc., an Alameda-based company engaged in research and development of innovative new products in the field of regenerative medicine utilizing stem cells and related technology, announced today that it has formed a new wholly owned subsidiary, BioTime Acquisition Corporation, to pursue opportunities and acquire assets and businesses in the fields of stem cells and regenerative medicine.
University of Kentucky Markey Cancer Center Researcher Jessica Blackburn has earned a prestigious National Institutes of Health's New Innovator Award, a grant totaling $1.5 million over five years to fund pediatric cancer research.
A unique compound originally isolated from sharks could prove to be a promising treatment for hepatitis B and C and other viral diseases, researchers say. Known as squalamine, the drug has not yet been tested as an antiviral agent in humans, but it has been given to hundreds of people enrolled in clinical trials designed to test its usefulness for other conditions. Researchers say they hope to begin human trials to test the compound's antiviral activity within the next year.
Dotmatics, a leading provider of scientific informatics solutions and services, announced MorphoSys will implement Vortex to analyse and visualise their screening data enabling rapid, informed decision making. MorphoSys choose Vortex because of the intuitive nature of the product and its extensive drug discovery capabilities.
With summer coming to a close, the American Society for Therapeutic Radiology and Oncology has published a new brochure to help the public understand the signs and symptoms of skin cancer as well as learn the treatment options for the disease.
› Verified 8 days ago
Justin Michael Cole, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 2901 W Kinnickinnic River Pkwy Ste 305, Milwaukee, WI 53215 Phone: 414-649-6000 | |
Mackenzie Lynn Reid, AA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-8700 Fax: 414-259-1522 | |
Aysha T Muhammad, CAA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-8700 Fax: 414-259-1522 | |
Anjali Rajan Menon, AA-C Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-8700 Fax: 414-259-1522 | |
Joseph Shaoul, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 945 N 12th St, Milwaukee, WI 53233 Phone: 414-219-2000 | |
Mrs. Lea Van Heule, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 2900 W Oklahoma Ave, Milwaukee, WI 53215 Phone: 231-288-3155 | |
Sarah Anderson, AA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 2900 W Oklahoma Ave, Milwaukee, WI 53215 Phone: 414-649-6000 |